Page last updated: 2024-09-03

omega-n-methylarginine and Leukemia

omega-n-methylarginine has been researched along with Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, H; Katsuoka, Y; Kubota, T; Miura-Takeda, S; Miyoshi-Higashino, M; Nomi, H; Takahashi, T; Tashiro-Yamaji, J; Ueda, H; Yamamoto, Y; Yoshida, R1

Other Studies

1 other study(ies) available for omega-n-methylarginine and Leukemia

ArticleYear
Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Aug-15, Volume: 179, Issue:4

    Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Fas Ligand Protein; Graft Rejection; Heart Transplantation; Leukemia; Macrophage-1 Antigen; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Knockout; Neoplasm Transplantation; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Perforin; Pore Forming Cytotoxic Proteins; Receptors, Antigen, T-Cell, alpha-beta; Skin Transplantation; Transplantation, Homologous

2007